Newcastle University
Toggle Main Menu
Toggle Search
Home
Browse
Latest
Policies
About
Home
Browse
Latest
Policies
About
ePrints
Browse by author
Browsing publications by
Dr James Knight.
Newcastle Authors
Title
Year
Full text
Katie Gristwood
Dr Antony Antoniou
Dr Hannah Walden
Dr James Knight
Annealing 1,2,4-triazine to iridium(iii) complexes induces luminogenic behaviour in bioorthogonal reactions with strained alkynes
2024
Tracey Luu
Katie Gristwood
Dr James Knight
Click Chemistry: Reaction rates and their suitability for biomedical applications
2024
Dr James Knight
In Vivo PET Detection of Lung Micrometastasis in Mice by Targeting Endothelial VCAM-1 Using a Dual-Contrast PET/MRI Probe
2024
Dr Toni Pringle
Erik Ramon Gil
Dr Jack Leslie
Professor Fiona Oakley
Professor Matthew Wright
et al.
Synthesis and Preclinical Evaluation of a
89
Zr-labelled Human Single Chain Antibody for Non-invasive Detection of Hepatic Myofibroblasts in Acute Liver Injury
2024
Katie Gristwood
Dr Saimir Luli
Dr Kenneth Rankin
Dr James Knight
Synthesis and
In Vitro
Evaluation of a HER2-Specific ImmunoSCIFI Probe
2023
Katie Gristwood
Dr Saimir Luli
Dr Kenneth Rankin
Dr James Knight
In situ
excitation of BODIPY fluorophores by
89
Zr-generated Cerenkov luminescence
2022
Dr Toni Pringle
Dr Corey Chan
Dr Saimir Luli
Dr Helen Blair
Dr Kenneth Rankin
et al.
Synthesis and
In Vivo
Evaluation of a Site-specifically Labeled Radioimmunoconjugate for Dual-Modal (PET/NIRF) Imaging of MT1-MMP in Sarcomas
2022
Dr Toni Pringle
Dr Oliver Coleman
Professor Akane Kawamura
Dr James Knight
The influence of degree of labelling upon cellular internalisation of antibody-cell penetrating peptide conjugates
2022
Dr James Knight
89
Zr-PET imaging of DNA double-strand breaks for the early monitoring of response following alpha- and beta-particle radioimmunotherapy in a mouse model of pancreatic ductal adenocarcinoma
2020
Dr Corey Chan
Dr Fabio Nicoli
Marcus Brookes
Zak Gamie
Tom Beckingsale
et al.
Advances in image enhancement for sarcoma surgery
2020
Dr James Knight
Early Detection in a Mouse Model of Pancreatic Cancer by Imaging DNA Damage Response Signalling
2020
Dr James Knight
Click Chemistry in Radiopharmaceutical Chemistry
2019
Dr James Knight
Dual-isotope imaging allows in vivo immunohistochemistry using radiolabelled antibodies in tumours
2019
Dr James Knight
PET Imaging of PARP Expression using [
18
F]olaparib
2019
Dr James Knight
Probing the Limits of Q-Tag Bioconjugation of Antibodies
2019
Dr James Knight
Targeting phosphatidylserine for radionuclide-based molecular imaging of apoptosis
2019
Dr James Knight
Imaging of Claudin-4 in Pancreatic Ductal Adenocarcinoma Using a Radiolabelled Anti-Claudin-4 Monoclonal Antibody
2018
Dr James Knight
Preservation of Ligand Functionality by Click Chemistry
2018
Dr James Knight
Translational molecular imaging in exocrine pancreatic cancer
2018
Dr James Knight
89
Zr-anti-gH2AX-TAT but not
18
F-FDG allows early monitoring of response to chemotherapy in a mouse model of pancreatic ductal adenocarcinoma
2017
Dr James Knight
Imaging the DNA damage response with PET and SPECT
2017
Dr James Knight
In Vivo Pretargeted Imaging of HER2 and TAG-72 Expression Using the HaloTag Enzyme
2017
Dr James Knight
18
F-Labeled wild-type annexin V: Comparison of random and site-selective radiolabeling methods
2016
Dr James Knight
Co-ordination behaviour of a novel tristhiourea tripodal ligand; Structural variations in a series of transition metal complexes
2016
Dr James Knight
Preclinical
89
Zr Immuno-PET of high-grade serous ovarian cancer and lymph node metastasis
2016
Dr James Knight
Scaling-down antibody radiolabeling reactions with zirconium-89
2016
Dr James Knight
Shaping and enforcing coordination spheres: Probing the ability of tripodal ligands to favour trigonal prismatic geometry
2016
Dr James Knight
Claudin-4 SPECT imaging allows detection of aplastic lesions in a mouse model of breast cancer
2015
Dr James Knight
Development of an enzymatic pretargeting strategy for dual-modality imaging
2015
Dr James Knight
PET and SPECT imaging for the acceleration of anti-cancer drug development
2015
Dr James Knight
PET imaging of DNA damage using
89
Zr-labelled anti-γH2AX-TAT immunoconjugates
2015
Dr James Knight
Bioorthogonal chemistry: implications for pretargeted nuclear (PET/SPECT) maging and therapy
2014
Dr James Knight
Crystal Structure of the Moonoprotonated Tripodal Ligand 2,2’-bipyrid-6-yl) Methanol
2014
Dr James Knight
Imaging DNA damage allows detection of preneoplasia in the BALB-
neu
T model of breast cancer
2014
Dr James Knight
Synthesis, complex stability and small animal PET imaging of a novel
64
Cu-labelled cryptand molecule
2014
Dr James Knight
Co-ordinative properties of a tripodal trisamide ligand with a capped octahedral preference
2013
Dr James Knight
Synthesis and evaluation of an
18
F-labelled norbornene derivative for copper-free click chemistry reactions
2013
Dr James Knight
Co-ordination behaviour of a novel bisthiourea tripodal ligand: Structural, spectroscopic and electrochemical properties of a series of transition metal complexes
2012
Dr James Knight
Synthesis and co-ordination chemistry of tris(picolyl-2-carboxyamido-6- pyridyl) methanol: A ligand with a strong preference for trigonal prismatic geometries
2012
Dr James Knight
A facile one-pot synthesis of a new cryptand via a Pd(II)-catalysed carbonylation reaction
2010
Dr James Knight
The synthesis and coordination chemistry of a tris-8-aminoquinoline tripodal ligand
2009